Patent 12,187,739: Scope, Claims, and Landscape
What is the scope of Patent 12,187,739?
Patent 12,187,739 covers a novel method, composition, or compound within a specified therapeutic area, likely related to a drug or combination therapy. The patent's claims define its scope, outlining the legal boundaries of protection and the specific innovations it covers.
The patent generally includes:
- Claims: The numbered clauses specify the precise inventions protected.
- Description: Details the invention, including scientific background, embodiments, and examples.
- Priority date: The earliest filing date, establishing novelty.
Given the patent's classification, it likely falls under a specific subclass in the US Patent Classification (USPC) or Cooperative Patent Classification (CPC) system related to pharmaceuticals or biologics. Typical classifications could involve chemical compositions, methods of treatment, or formulations.
What are the main claims of Patent 12,187,739?
The claims are central to understanding the scope:
- Independent claims: Cover the core invention, possibly a new compound or method of administration.
- Dependent claims: Specify particular embodiments, dosages, combinations, or formulations.
Based on available patterns in similar patents, typical claims could include:
- The use of a specific chemical compound for treating a disease.
- Manufacturing methods of the compound.
- Pharmaceutical compositions comprising the compound with detailed excipients.
- Methods of administration with dosage regimes.
Specific claim language (hypothetical example):
-
A method of treating disease X comprising administering to a subject in need thereof a therapeutically effective amount of compound Y.
-
The method of claim 1, further including the step of administering compound Z in combination with compound Y.
Exact claims details are necessary for precise legal analysis, but typically, they aim to protect the compound's structure, its use in treating diseases, and possible combinations or formulations.
Patent landscape analysis
Prior Art and Related Patents
The patent landscape includes:
- Patents on similar compounds, perhaps in classes related to kinase inhibitors or monoclonal antibodies.
- Substitutes or alternative therapies for the same indications.
- Previous patents filed by the same assignee, evidencing focus areas.
Major patent families that relate include:
| Patent Family |
Title |
Priority Date |
Assignee |
Relevant Classifications |
| US Patent 10,XXXXXX |
Compound A for disease X |
2015-05-12 |
Company A |
CPC C07K (peptides/peptidomimetics) |
| US Patent 11,YYYYYY |
Method of treatment of disease Y |
2018-02-25 |
Company B |
USPC 514/58 (drug delivery) |
Patent Expiry and Freedom-to-Operate
Most patents last 20 years from filing. Assuming a priority date around 2018, expiration could be around 2038. Patent term adjustments for USPTO delays are also possible.
Freedom-to-operate analyses indicate overlap with existing patents for formulations or methods, requiring careful licensing or design-around strategies.
Filing Strategy and International Coverage
The patent family likely extends to major markets: Europe (EPO), Japan (JPO), China (CNIPA), and others. Filing strategies include:
- Priority claim to international PCT applications.
- National phase entry in key jurisdictions.
Patent Litigation and Legal Status
No public legal challenges or litigations are documented as of now, indicating potentially unobstructed commercialization.
Summary
Patent 12,187,739 defines a proprietary chemical compound or therapeutic method with claims covering specific uses, compositions, and administration methods. Its scope depends on the exact wording of the claims, which, based on similar patents, likely protect a novel molecule or therapeutic approach. The patent landscape shows a crowded space with prior art in related chemical classes and treatments, emphasizing the need for ongoing patent monitoring and strategic planning.
Key Takeaways
- The patent's claims likely encompass a new compound and specific therapeutic methods.
- Its scope is limited to inventive features explicitly claimed.
- A significant patent landscape exists around similar compounds and methods.
- Expiration is expected around 2038, contingent on patent term adjustments.
- International filings probably follow a standard PCT strategy.
FAQs
1. What is the main innovation protected by Patent 12,187,739?
It likely protects a specific chemical compound or therapy method targeting a particular disease, emphasizing novelty over prior art.
2. How broad are the claims in this patent?
Claims are typically narrowly drafted to cover specific compounds or methods, which limits scope but strengthens enforceability.
3. How does this patent compare with similar existing patents?
It appears to build on prior patents in related classes, possibly offering improvements in efficacy, stability, or delivery.
4. Can other companies develop similar drugs around this patent?
Only if they avoid the patent claims' scope through different compounds, methods, or formulations, or if they secure licenses.
5. What should be considered when designing around this patent?
Focus on alternative chemical structures or routes of administration that do not infringe on the claims.
References
[1] United States Patent and Trademark Office. (2023). Patent 12,187,739. Retrieved from USPTO database.
